Ipsen – November 2025 – Monthly information relative to the total number of voting rights and shares composing the share capital
Monthly information relative to the total number of voting rights and shares composing…
Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in Lower-Risk MDS at ASH 2025
– New findings demonstrate a 72% HI-E response rate at Week 16…
VELO AND THE McLAREN FORMULA 1 TEAM’S FAN-DESIGNED LIVERY TAKES CENTRE STAGE AS LANDO NORRIS WINS 2025 DRIVERS’ CHAMPIONSHIP IN ABU DHABI
ABU DHABI, UAE, Dec. 8, 2025 /PRNewswire/ -- Yesterday, the McLaren Formula 1®…
Mantle “2025 RWApped”: A Year of Unstoppable MoMNTum and Global RWA Expansion
SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- In 2025, Mantle entered a new phase…
Mercury Showcases Expanding Portfolio of Electronic Warfare Capabilities at AOC 2025
December 08, 2025 07:00 ET | Source: Mercury Systems Inc ANDOVER, Mass.,…
Global Stars Confirmed as the Games of the Future Abu Dhabi 2025 Finalises Full Line-Up
Some of the biggest names in phygital sports and esports from around…
Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025
December 07, 2025 16:00 ET | Source: Wave Life Sciences USA, Inc.…
14th Olympic Summit on 11 December 2025 Information for the media
05 December 2025 - The International Olympic Committee (IOC) will host the 14th…
ORIC Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and 2L NSCLC Patients with EGFR Exon 20 Mutations at the ESMO Asia Congress 2025
December 05, 2025 20:00 ET | Source: ORIC Pharmaceuticals Highly differentiated 1L…
AVComparatives triumphs at 2025 “Tiroler Innovationspreis 2025”
INNSBRUCK, Austria, Dec. 5, 2025 /PRNewswire/ -- The independent cybersecurity testing authority AV‑Comparatives…
